DD101403A5 - Verfahren zur herstellung von phenylimidazolidinonen - Google Patents

Verfahren zur herstellung von phenylimidazolidinonen

Info

Publication number
DD101403A5
DD101403A5 DD163478A DD16347872A DD101403A5 DD 101403 A5 DD101403 A5 DD 101403A5 DD 163478 A DD163478 A DD 163478A DD 16347872 A DD16347872 A DD 16347872A DD 101403 A5 DD101403 A5 DD 101403A5
Authority
DD
German Democratic Republic
Prior art keywords
phenylimidazolidinones
preparation
Prior art date
Application number
DD163478A
Other languages
German (de)
English (en)
Inventor
Anton Mentrup
Ernst-Otto Renth
Kurt Schromm
Peter Danneberg
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DD101403A5 publication Critical patent/DD101403A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD163478A 1971-06-07 1972-06-06 Verfahren zur herstellung von phenylimidazolidinonen DD101403A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT492071A AT311956B (de) 1971-06-07 1971-06-07 Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze

Publications (1)

Publication Number Publication Date
DD101403A5 true DD101403A5 (de) 1973-11-05

Family

ID=3569889

Family Applications (1)

Application Number Title Priority Date Filing Date
DD163478A DD101403A5 (de) 1971-06-07 1972-06-06 Verfahren zur herstellung von phenylimidazolidinonen

Country Status (20)

Country Link
AR (7) AR200112A1 (fr)
AT (1) AT311956B (fr)
AU (1) AU473287B2 (fr)
BE (1) BE784475A (fr)
BG (1) BG22822A3 (fr)
CA (1) CA1011336A (fr)
CH (7) CH583729A5 (fr)
DD (1) DD101403A5 (fr)
DE (1) DE2223751A1 (fr)
ES (1) ES403542A1 (fr)
FR (1) FR2140492B1 (fr)
GB (1) GB1391491A (fr)
HU (1) HU165493B (fr)
IE (1) IE37812B1 (fr)
IL (1) IL39620A (fr)
NL (1) NL7207701A (fr)
NO (1) NO136841C (fr)
SE (1) SE392902B (fr)
SU (8) SU453839A3 (fr)
ZA (1) ZA723840B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822678A1 (de) * 1998-05-20 1999-11-25 Bayer Ag Substituierte 1,3-Diaza-2-(thi)oxo-cycloalkane
CA2568609A1 (fr) * 2003-05-28 2004-12-09 Imotep Inc. Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la proliferation cellulaire pathogene non cancereuse et les maladies y etant associees
WO2004106291A1 (fr) * 2003-05-28 2004-12-09 Imotep Inc. Composes d'uree haloethyle et leur utilisation en vue d'attenuer, d'inhiber ou de prevenir la migration de cellules cancereuses
RU2497810C1 (ru) * 2012-06-28 2013-11-10 Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" Способ получения n,n-диарилзамещенных 2-трихлорометилимидазолидинов

Also Published As

Publication number Publication date
ZA723840B (en) 1974-02-27
AU4312972A (en) 1973-12-13
CA1011336A (en) 1977-05-31
IE37812L (en) 1972-12-07
SU493067A3 (ru) 1975-11-25
IL39620A (en) 1977-02-28
CH583729A5 (fr) 1977-01-14
AR205522A1 (es) 1976-05-14
IL39620A0 (en) 1972-08-30
CH589644A5 (fr) 1977-07-15
BE784475A (fr) 1972-12-06
FR2140492A1 (fr) 1973-01-19
SE392902B (sv) 1977-04-25
FR2140492B1 (fr) 1976-03-05
AR207109A1 (es) 1976-09-15
BG22822A3 (fr) 1977-04-20
SU499806A3 (ru) 1976-01-15
SU503516A3 (ru) 1976-02-15
SU492085A3 (ru) 1975-11-15
CH591475A5 (fr) 1977-09-15
AR203017A1 (es) 1975-08-08
CH589646A5 (fr) 1977-07-15
HU165493B (fr) 1974-09-28
GB1391491A (en) 1975-04-23
NL7207701A (fr) 1972-12-11
NO136841B (no) 1977-08-08
IE37812B1 (en) 1977-10-26
ES403542A1 (es) 1975-05-01
DE2223751A1 (de) 1972-12-28
CH589645A5 (fr) 1977-07-15
SU509228A3 (ru) 1976-03-30
SU453839A3 (ru) 1974-12-15
AR202903A1 (es) 1975-07-31
AR200139A1 (es) 1974-10-24
AR200112A1 (es) 1974-10-24
AU473287B2 (en) 1973-12-13
AT311956B (de) 1973-12-10
AR202904A1 (es) 1975-07-31
CH573425A5 (fr) 1976-03-15
CH590269A5 (fr) 1977-07-29
SU505358A3 (ru) 1976-02-28
SU498907A3 (ru) 1976-01-05
NO136841C (no) 1977-11-16

Similar Documents

Publication Publication Date Title
AT315819B (de) Verfahren zur Herstellung von Nitrodiphenylaminverbindungen
AT336181B (de) Verfahren zur herstellung von delta3-7-acylamido-desacetoxycephalosporansauren
AT325201B (de) Verfahren zur herstellung von 7-acylamidocephalosporamsäuren
AT313923B (de) Verfahren zur Herstellung von Alkenylsilanen
CH535253A (de) Verfahren zur Herstellung von substituierten Benzthiazolen
AT313471B (de) Verfahren zur Herstellung von 7-Halogen-7-deoxy-lincomycinen
AT320641B (de) Verfahren zur Herstellung von Oxazolinen
AT315829B (de) Verfahren zur Herstellung von 4-Halogenmethylcumarinen
AT312803B (de) Verfahren zur Herstellung von 7-Amino-desacetoxy-cephalosporansäure
AT310714B (de) Verfahren zur Herstellung von 4-Oxocapronitril
AT309679B (de) Verfahren zur Herstellung von 6-Desoxytetracyclinen
AT324553B (de) Verfahren zur herstellung von 3-alkylthiomethylcephalosporinen
AT319211B (de) Verfahren zur Herstellung von α-Amino-2-hydroxyphenylessigsäuren
AT316560B (de) Verfahren zur Herstellung von 2,4-Diamino-5-benzylpyrimidinen
AT306032B (de) Verfahren zur Herstellung von 4-Hydroxy-6-halogenmethyl-pyrimidinen
AT310960B (de) Verfahren zur Herstellung von 6α-Methyl-19-nor-pregnenen
DD101403A5 (de) Verfahren zur herstellung von phenylimidazolidinonen
AT326816B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
AT327910B (de) Verfahren zur herstellung von 5-acyl-iminostilben-derivaten
AT331249B (de) Verfahren zur herstellung von 5-benzylpyrimidinen
AT318823B (de) Verfahren zur Herstellung von 16-Carboxy-17-methoxy-eburnan
AT321258B (de) Verfahren zur Herstellung von Azinen
CH543571A (de) Verfahren zur Herstellung von 3,10-Dichlorchinacridon
AT312574B (de) Verfahren zur Herstellung von Cyclopropylmethylalkylaminen
AT315191B (de) Verfahren zur Herstellung von Arylsulfonylharnstoffen